1
Secretagogin was detected in plasma from carcinoid patients with distant metastasis.
2
HIV-1 drug resistance mutations are currently detected in plasma viral RNA.
3
Both tumor-derived and systemic response proteins are detected in plasma from cancer patients.
4
Endotoxin was detected in plasma in 40% of febrile episodes regardless of aetiology.
5
CR-6 was detected in plasma and brain by HPLC.
6
The T315I mutation was detected in plasma and BM but not PB cells in one patient.
7
Tumor RNA has been detected in plasma from cancer patients and is associated with poor prognosis.
8
Although radiometabolites were detected in plasma, urine and liver samples, radiometabolites were not found in brain samples.
9
Results: Brilliant blue G was not detected in plasma from all five cases at the three points of measurement.
10
Results: TS mRNA was detected in plasma in 47% of patients, showing significant differences from healthy controls.
11
The active metabolite (Ro 12-5637) could only be detected in plasma.
12
The metabolites were detected in plasma 30 min post-dose and peaked 3-5 h after the dose.
13
Comparison of whole blood and plasma samples from the same pregnant woman suggested that placental genes are more easily detected in plasma.
14
In discordant patients, 13 mutations were detected in plasma, 11 in BM cells and 9 in PB cells.
15
Purpose: Increases in androgen receptor (AR) copy number (CN) can be detected in plasma DNA when patients develop metastatic castration-resistant prostate cancer.
16
Peri-tumoral injection in tumor-bearing mice showed PTX localization in the tumor 2 hours after administration, with no drug detected in plasma or other organs.
